Education

Biography

Mohammed Hossein Shamssain is an Associate Professor at the College of Pharmacy and Health Sciences (COPHS) at Ajman University (AU). He got his M.Sc and Ph.D Degrees from Loughborough University , United Kingdom. He got his Certificate for Higher Education (Cert Ed) from the University of Sunderland, United Kingdom. He has also attending many workshops, seminars and  Continuing Medical Education courses in respiratory pathophysiology, pharmacotherapy and management of asthma and COPD (Chronic Obstructive Pulmonary Disease) in Europe, USA, and UAE, and has obtained relevant certificates including CME for these activities.

Academically, he has been teaching pharmacology and toxicology courses at undergraduate and pharmacovigilance, drug abuse, research methodology and biostatistics at postgraduate levels at COPHS. He has been actively involved in organizing three international conferences on Asthma and COPD at COPHS, supervising research projects both at undergraduate and postgraduate levels (almost 40 theses; M.Sc Clinical Pharmacy). He has also participated in curriculum development and in the accreditation programs for undergraduate and postgraduate levels at COPHS.

Before joining AU, Dr Mohammed Shamssain has worked in many universities world-wide. For example, he has established the ISAAC Centre for the North East of England (the International Study of Asthma and Allergies in Childhood) in 1996 when he was a Senior Lecturer (Associate Professor) at the University of Sunderland, United Kingdom. He has supervised many graduation, M.Sc, M.Phil and Ph.D research projects.

Research Interest

• Respiratory Physiology and Respiratory pathophysiology
• Pharmacology
• Therapeutics and Epidemiology
• Pharmacotherapy of Asthma & COPD
• Respiratory and Environmental Health and Health Research

Scientific Activities

Publications

Books / Book Chapter

1. Shamssain MH. Respiratory effects of occupational and environmental pollution in Southern African farmers in the Transkei. In Agricultural health and Safety: Workplace, Environment, Sustainability. Editors: McDuffie HH, Dosman JA, Semchuk KM, Olenchock SA, Senthilselvan CRC Press Inc, Lewis Publishers, USA, 1995.

International Refereed Journals

1. Mohammed Shamssain. Prevalence and severity of asthma, rhinitis and eczema in pre-school children in the UAE (In Preparation 2017)
2. Mohammed Shamssain. Editorial: Advanced Aerosol Delivery Devices for Potential Cure of Acute and Chronic Diseases: New Challenges. SciFed Pharmaceutics Journal (In Press 2017.
3. Mohammed Shamssain. Editorial: Nanoparticle-Based Drug Delivery For the Management of Chronic Lung disease. SciFed Drug Delivery Research Journal (In Press 2017)
4. Saba Salem Al-Hemyari, Mohammed Shamssain. Knowledge, believes and behaviors of university students toward osteoporosis. EJPMR 2017; 4(2): 1-9.
5. Marwah Ayad Alhamadani, Mohammed Shamssain. Awareness of hypertension among patients in the UAE. EJPMR 2017; 4(2): 24-31.
6. Khadeija Ahmed Saeed Al Marshoudi, Mohammed Shamssain. Cardiovascular risk factors among adults in the United Arab Emirates. EJPMR 2017; 4(2): 64-75.
7. Asma Ibrahim Elkish, Hanan Naser Sandid, Maitha Mohammed Alaryani, Marah Bassam Elkhatib, Mohammed Shamssain. Health problems and medication self-management among university students in the UAE. EJPMR 2017; 4(2): 10-23.
8. Mohammed Shamssain, Aya Rahman Lafta, Saeed Abdulla. Long-term effects of overweight and breastfeeding on asthma, rhinitis and eczema in UAE schoolchildren. EJPMR 2016.
9. Adnan Moneam, Wahbi Nour Eddin, Ahmad Taqi, Aya Rahman Lafta,  Mohammed  Shamssain, Moyad Shahwan, Samir Haj Bloukh . The Prevalence and Factors Affecting Acne Vulgaris Among University Students.. European Journal of Pharmaceutical and Medical Research 2016; 3(6): 101-107.
10. Saeed Abdulla, Mohammed Shamssain, Aya Rahman Lafta and Nageeb Hassan. Prevalence and severity of asthma, rhinitis and eczema in schoolchildren in the UAE. EJPMR 2016; 3(9): 464-467.
11. Aya Rahman Lafta, Mohammed Shamssain. Comparison of the prevalence rates of asthma and allergies between UAE and Iraqi schoolchildren. E|JPMR 2016; 3(3):15-22.
12. Sahar MA, Shamssain M, Shahwan M. prevalence and Impact of Dysmenorrhea on Health Related Quality of Life in the United Arab Emirates. EJPMR 2016, 3(2): 77-86.
13. Mustafa Nafee Al Kubais, Nageeb Abdul Galil Hassan, Mohammed Shamssain. Association between adherence to diabetes medication and glycemic control. International Journal of Research and Development in Pharmacy and Life Sciences 2015; 5(1): 1915-1920.
14. Mohammed Hassanein, Mohammed Shamssain, Nageeb Hassan. Health Related Quality of Life Among Osteoarthritis Patients: A comparison of Traditional Non-Steroidal Anti-inflammatory Drugs and Selective COX-2 Inhibitors in the United Arab Emirates Using the SF-36. Pharmacology & Pharmacy 2015, 6: 232-240.
15. Triki Moez, Haithem Rebai, Chirine Aouichaoui, Mohammed Shamssain. Comparative Study of Bronchial Hyperresponsiveness between Football and Judo groups in prepubertal boys. Asian J Sports Med 2015; 6(2): 1-8.
16. Jalal Omer, Mohammed Shamssain, Ken McGerry. Monitoring histological changes in oral mucosa using AgNORs as biomarkers for oxygenic stress in smokers and COPD patients. IOSR Journal of Pharmacy 2015, Volume 5 (Issue 4): 24-29.
17. Sundos Qasssim, Zakia Metwaly, Mohammed Shamssain, Yassin Al Hariri. Spontaneous reporting of adverse drug reactions in UAE: Obstacles and motivation among community pharmacists. International Journal of Pharmaceutical Sciences and Research 2014; 5 (10):4203-4208.
18. Sundos Qasssim, Zakia Metawali, Mohammed Shamssain, Yasin Hariri. Reporting Adverse Drug reactions: Evaluation of Knowledge, Attitude and Practice among Community Pharmacists in UAE. IOSR Journal of Pharmacy 2014; 4(4): 17-23.
19. Ning Song, Shamssain Mohammed. Jin Zhang , et al. Prevalence , severity and risk factors of asthma , rhinitis, and eczema in a large group of Chinese  Schoolchildren. J Asthma 2014; 51(3): 232-242.
20. Sawsan Shanableh, Abdulmula Abdulkarem, Mohammed Shamssain, Fadi Sarhan. Quality of life of hypertensive patients on different types of antihypertensive medications. IOSR Journal of Pharmacy 2014; 4(5): 23-28.
21. Sarah Amir Al Akshar, Mohammed Shamssain, Zakia Metwaly. Pharmacists perception of community Pharmacy practice in UAE: An overview.IOSR Journal of Pharmacy 2014; 4(6): 47-56.
22. Sarah Amir Al Akshar, Zakia Metwaly, Mohammed Shamssain. Patients’ perception of community pharmacy practice in UAE: An Overview. IOSR Journal of Pharmacy 2014; 4 (Issue 11): 8-14.
23. Triki M, Tabka Z, Shamssain M. Comparative study of aerobic performance between football and Judo groups in prepubertal boys. Asian Journal of Sports Medicine 2013; 4(3): 165-174.
24. Anan S Jarab, Salam G Alqudah, Maher Khdour, Mohammed Shamssain, Tareq L Mukattash. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2012 Feb; 34 (1):53-62
25. Asher MI, Stewart AW, Mallol J, Montefort M, Lai CKW, Aït-Khaled N, Odhiambo J, and the ISAAC Phase One Study Group.(Study group includes Shamssain MH). Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? A review of the ecological analyses of ISAAC Phase One. Respiratory Research. 2010; 11(8)
26. Ellwood P, Asher MI, Stewart AW and the ISAAC Phase III Study Group (Study group includes Shamssain MH). The impact of the method of consent on response rates in the ISAAC time trends study. Int J Tuberc Lung Dis. 2010 Aug; 14(8):1059-65.
27. Ansari K, Shamssain M, Farrow M, Keaney NP. Hospital-at-home Care for exacerbations of chronic obstructive pulmonary disease: an observational cohort study of patients managed in hospital or by nurse practitioners in the community. Chronic Respiratory Disease 2009, 6:69-74.
28. Anderson HR, Ruggles R, Pandey KD, Kapetenakis V, Brunekreef B, Lai CKW, Strachan DP, Weiland SK, and the ISAAC Phase One Study Group. (Study group includes Shamssain MH). Ambient particulate pollution and the world-wide prevalence of asthma, rhinoconjunctivitis and eczema in children: Phase One of the International Study of Asthma and Allergies in Childhood (ISAAC). Occup Environ Med 2010; 67(5): 293-300.
29. Odhiambo J, Williams H, Clayton T, Robertson C, Asher MI, and the ISAAC Phase Three Study group. (Study group includes Shamssain MH). Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three J Allergy Clin Immunol. Dec 2009; 124(6):1251-8.
30. Aït-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J, and the ISAAC Phase Three Study Group. (Study group includes Shamssain MH). Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009; 64: 123–148.
31. Lai CKW, Beasley R, Crane J, Foliaki S, Shah J, Weiland S, and the ISAAC Phase Three Study Group. (Study group includes Shamssain MH). Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64: 476–483.Epub Feb 2009.
32. Ellwood P, Williams H, Aït-Khaled N, Björkstén B, Robertson C, and the ISAAC Phase III Study Group. (Study group includes Shamssain MH). Translation of questions: The International Study of Asthma and Allergies in Childhood (ISAAC) experience. Int J Tuberc Lung Dis.September 2009; 13(9): 1174-1182.
33. Björkstén B, Clayton T, Ellwood P, Stewart A, Strachan D, and the ISAAC Phase Three Study Group. (Study group includes Shamssain MH). Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 2008; 19(2): 110-24.
34. Williams H, Stewart A, von Mutius E, Cookson B, Anderson HR, and the ISAAC Phase One and Three Study groups. (Study group includes Shamssain MH). Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008; 121(4): 947-54.
35. Shamssain MH. Trends in the prevalence and severity of asthma, rhinitis, and atopic eczema in 6- to 7- and 13- to 14- yr- old children from the north east of England. Pediatr Allergy Immunol 2007; 18: 149-153.
36. Ansari K, Shamssain MH, Keaney NP, Burns G, Farrow M. Predictors of quality of life in Chronic Obstructive Pulmonary Disease (COPD) patients with different frequency of exacerbations. Pakistan Journal of Medical Sciences 2007; 23(4): 490-496.
37. Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, Robertson C, and the ISAAC Phase Three Study Group. (Study group includes Shamssain MH). Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62(9): 758-66.
38. Shamssain MH. The association between being overweight or obesity and respiratory symptoms in schoolchildren. Pediatric Asthma, Allergy & Immunology 2006, 19(1): 19-25.
39. Shamssain MH, Rowell F. Indoor level of proteases as a marker for respiratory illness. Inter J Sci Res 2006; 15: 1-6.
40. Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, Williams H, and the ISAAC Phase Three Study Group.(Study group includes Shamssain MH). Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368(9537): 733-743.
41. Foliaki S, Kildegaard Nielsen S, Björkstén B, von Mutius E, Cheng S, Pearce N, and the ISAAC Phase One Study Group. (Study group includes Shamssain MH). Antibiotic sales and the prevalence of symptoms of asthma, rhinitis, and eczema: The International Study of Asthma and Allergies in Childhood (ISAAC). Int J Epidemiol 2004; 33(3): 558-63.
42. Weiland SK, Hüsing A, Strachan D, Rzehak P, Pearce N, and the ISAAC Phase One Study Group. (Study group includes Shamssain MH). Climate and the prevalence of symptoms of asthma, allergic rhinitis and atopic eczema in children. Occup Environ Med 2004; 61(7): 609-15.
43. Burr ML, Emberlin JC, Treu R, Cheng S, Pearce NE, and the ISAAC Phase One Study Group. (Study group includes Shamssain MH). Pollen counts in relation to the prevalence of allergic rhinoconjunctivitis, asthma and atopic eczema in the International Study of Asthma and Allergies in Childhood (ISAAC). Clin Exp Allergy 2003; 33(12): 1675-80.
44. Crane J, Mallol J, Beasley R, Stewart A, Asher MI, on behalf of the ISAAC Phase One Study Group. (Study group includes Shamssain MH). Agreement between written and video questions for comparing asthma symptoms in ISAAC. Eur Respir J 2003; 21(3): 455-61.
45. Shirtcliffe P, Weatherall M, Beasley R, on behalf of the ISAAC Phase One Study Group. (Study group includes Shamssain MH). An inverse correlation between estimated tuberculosis notification rates and asthma symptoms. Respirology 2002; 7(2): 153-5.
46. Shamssain MH, Shamsian N. Prevalence of asthma, rhinitis and eczema in -schoolchildren aged 13-14 years. Annals  of Allergy, Asthma, & Immunololgy 2001; 86: 428-432.
47. Anderson HR, Poloniecki JD, Strachan DP, Beasley R, Björkstén B, Asher MI, and the ISAAC Phase One Study Group. (Study group includes Shamssain MH). Immunization and symptoms of atopic disease in children: Results from the International Study of Asthma and Allergies in Childhood. Am J Publ Health 2001; 91(7): 1126-9.
48. Ellwood P, Asher MI, Björkstén B, Burr M, Pearce N, Robertson CF, and the ISAAC Phase One Study Group. (Study group includes Shamssain MH). Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: An ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. Eur Respir J 2001; 17(3): 436-443.
49. Mitchell EA, Stewart AW, on behalf of the ISAAC Phase One Study Group. (Study group includes Shamssain MH). The ecological relationship of tobacco smoking to the prevalence of symptoms of asthma and other atopic diseases in children: The International Study of Asthma and Allergies in Childhood (ISAAC). Eur J Epidemiol 2001; 17(7): 667-73.
50. Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW, on behalf of the ISAAC Steering Committee and the ISAAC Phase Three Study Group. (Study group includes Shamssain MH). ISAAC Phase Three Manual. Auckland.July 2000.ISBN 0-473-06910-5.
51. Shamssain MH.  Shamsian N. Prevalence and severity of asthma, rhinitis and eczema: The North East Study. Arch Dis Child 1999; 81: 313-317. 
52. Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson HR, Asher MI, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Shah J, Sibbald B, Strachan D, von Mutius E, Weiland S. (Study group includes Shamssain MH). Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999; 103(1 Pt 1): 125-38.
53. Shamssain MH. Forced expiratory indices in normal black Southern African children aged 6-19 years. Thorax 1991; 46: 175-179.
54. Shamssain MH. Growth of normal black Southern African children aged 6-19 years. J Trop Ped 1991; 37: 4-12.
55. Asher MI, Weiland SK, on behalf of the ISAAC Steering Committee. (Study group includes Shamssain MH). The International Study of Asthma and Allergies in Childhood (ISAAC). Clin Exp Allergy 1998; 28 Suppl 5: 52-66.
56. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. (Study group includes Shamssain MH). Worldwide variation in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351(9111): 1225-32.
57. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. (Study group includes Shamssain MH). Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12(2): 315-335.
58. Shamssain MH. Ogston SA Thompson J. Forced expiratory indices in normal Libyan children aged 6-19 years. Thorax 1988: 43: 467-470.
59. Shamssain MH, Thompson J, Ogston SA. Effects of cement dust on lung function in Libyans. Ergonomic 1988; 31: 1299-1303.
60. Shamssain MH. Forced expiratory indices in normal Libyan men. Thorax 1988; 43: 923-925.
61. Strachan D, Sibbald B, Weiland S, Aït-Khaled N, Anabwani G, Anderson HR, Asher MI, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Robertson C, Shah J, Stewart A, von Mutius E, Williams H. (Study group includes Shamssain MH). Worldwide Variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997; 8(4): 161-76.
62. Shamssain MH, Shamsian N. Pulmonary function and symptoms in a group of weavers. Ann Human Biol 1997; 24(4): 299-306.
63. Wang M, McCabe L, Hankinson JL, Shamssain MH, Lapp NL, Banks DE. Longitudinal and cross-sectional analyses of lung function in steel workers. Am J Respir CCM 1996; 153: 1907-13.
64. Shamssain MH. Respiratory symptoms and pulmonary function in flour processing workers in a baking industry. Am J Ind Med 1995; 27(3): 359-366.                                      
65. McEwan SR, Arthur P, Shamssain MH, Scott A, Whitehorn M, Packard CJ, Ritchie LD, Forbes CD. Heart and arterial disease risk factor levels in the Scottish workforce: Cross-sectional study of risk factor levels. Scot Med J 1995; 40: 43-49.
66. Shamssain MH. Pulmonary function in normal non-smoking black Southern African adults. Respir Med 1994; 88: 287-291.
67. Shamssain MH. Pulmonary function and symptoms in workers exposed to wood dust. Thorax 1992; 47: 84-87.
68. Shamssain MH, Thompson J. A comparative study of pulmonary function and body composition in Scottish and Libyan schoolchildren aged 12-17 years. J Trop Ped 1992; 38: 121-123.
69. Shamssain MH. Growth rate and anthropometry of a Libyan population. J Trop Ped 1989; 35: 306-311.